Showing results (431-440 of 530) with videos related to

Sort By:
Pageof 53
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2018
The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary TuberculosisElin M Svensson, Robin J Svensson, Lindsey H M Te Brake, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2018
Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of TuberculosisCharles A Peloquin, Patrick P J Phillips, Carole D Mitnick, et al.
American Journal of Respiratory and Critical Care Medicine|July 9, 2011
CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmapPayam Nahid, Jussi Saukkonen, William R Mac Kenzie, et al.
Emerging Infectious Diseases|March 2, 2025
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with DiabetesEkaterina V Kurbatova, William C Whitworth, Lakshmi Praveena Peddareddy, et al.
Proceedings. Biological Sciences|July 12, 2013
Habitat filtering across tree life stages in tropical forest communitiesC A Baldeck, K E Harms, J B Yavitt, et al.
International Journal of Geriatric Psychiatry|October 15, 2016
Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)Martin Knapp, Derek King, Renée Romeo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 30, 2022
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349)April C Pettit, Patrick P J Phillips, Ekaterina Kurbatova, et al.
The New England Journal of Medicine|April 29, 2026
Pulmonary Tuberculosis Detection with MiniDock MTB Using Swab SamplesSeda Yerlikaya, Masuzyo Chirwa, Bukola Ajide, et al.
Pageof 53